Two International Drug Manufacturers Earn Warning Letters Over Quality Controls

Drug Industry Daily
A A
The FDA issued warning letters to two international drug manufacturers for breaching GMP standards by failing to develop procedures to maintain the appropriate quality controls.

To View This Article:

Login

Subscribe To Drug Industry Daily